Immune suppressor cells called MDSCs (myeloid-derived suppressor cells) may be important in developing treatments for advanced prostate cancer, according to a study at The University of Texas MD Anderson Cancer Center.
Dec 21, 2015
0
16
New research published in the Journal of Leukocyte Biology, helps explain why Staphylococcus aureus infections take hold after prosthetic surgery that are resistant to both the body's natural defenses as well as antibiotic ...
Dec 1, 2015
0
0
(HealthDay)—For patients with biochemically recurrent prostate cancer, treatment with white button mushroom (WBM) powder may reduce prostate-specific antigen (PSA) levels, according to a study published in the Sept. 1 issue ...
Sep 3, 2015
0
71
Weill Cornell Medical College researchers have shown for the first time that a gene previously implicated in blood vessel formation during embryonic development and tumor growth also induces immune suppression during tumor ...
Apr 29, 2015
0
9
Using a mouse model of rheumatoid arthritis, scientists have discovered that a form of cellular immunotherapy by intravenous administration of monocytic myeloid-derived suppressor cells, or M-MDSCs, might be an effective ...
Mar 6, 2015
0
7
A study led by St. Jude Children's Research Hospital scientists has identified the population of white blood cells that tumors use to enhance growth and suppress the disease-fighting immune system. The results, which appear ...
Dec 18, 2014
2
0
A new editorial paper titled "Neutrophil PAD4: how does it function in cancer beyond promoting NETosis?" has been published in Oncotarget.
Oct 30, 2023
0
11
Myeloid derived suppressor cells (MDSCs), produced in the bone marrow as part of the human immune response to a tumor, may have a potent immunoregulatory role following viral infection. The similarities and differences between ...
Jan 26, 2017
0
0
